News Release April 16, 2008 FDA's investigation of generic antidepresssant called inadequate by ConsumerLab.com and The People's Pharmacy WHITE PLAINS, NEW YORK AND DURHAM, NORTH CAROLINA APRIL 16, 2008 After waiting more than six months for results of the FDA's investigation of a generic version of Wellbutrin XL 300 (Budeprion XL 300), ConsumerLab
The total cell counts and total protein concentration in BALF, indicators of cellular infiltration and increased alveolar permeability, respectively, were significantly elevated by LPS
The capsule format also minimizes exposure risk for lab personnel while maintaining compound stability throughout experimental protocols
The benzyl alcohol preservative system inhibits microbial growth, maintaining vial integrity across multiple research preparations from a single container
Supplementary material The Supplementary Material for this article can be found online at: References 1 ChenJ.WangM.JoyceA.DeFrancoD.KavosiM.XuX.et al (2014)
A 1mg dose at this concentration is only 10 units on a syringe